REVVITY, INC Restructuring and Related Cost, Incurred Cost
REVVITY, INC (RVTY) reported Restructuring and Related Cost, Incurred Cost of $400.00 thousand for the 6-month period ending 2011-07-03, per its 10-Q filed 2011-08-10.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RestructuringAndRelatedCostIncurredCost · last filed 2011-08-10
- 2011-07-03: Restructuring and Related Cost, Incurred Cost 6 month $400.00K.
| Period end | Restructuring and Related Cost, Incurred Cost 6 month |
|---|---|
| 2011-07-03 | $400.00K 10-Q · filed 2011-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| METTLER TOLEDO INTERNATIONAL INC/ (MTD) | $30.436B | 30.62 | |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |